Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Uceris Generic Name & Formulations
Legal Class
Rx
General Description
Budesonide 9mg; ext-rel tabs.
Pharmacological Class
Glucocorticoid.
How Supplied
Ext-rel tabs—30
Manufacturer
Generic Availability
NO
Uceris Indications
Indications
Induction of remission in patients with active, mild to moderate ulcerative colitis.
Uceris Dosage and Administration
Adult
Swallow whole. 9mg once daily in the AM for up to 8 weeks.
Children
Not established.
Uceris Contraindications
Not Applicable
Uceris Boxed Warnings
Not Applicable
Uceris Warnings/Precautions
Warnings/Precautions
Active or quiescent tuberculosis, untreated fungal, bacterial, systemic viral or parasitic infections. Supplement with systemic glucocorticosteroid in surgery or other stress situations. Caution when transferring from steroids with high systemic availability (monitor). May unmask allergies previously controlled by systemic corticosteroids. If exposed to chickenpox or measles, consider immune globulin or antiviral prophylactic therapies. Hypertension. Diabetes. Osteoporosis. Peptic ulcer. Glaucoma. Cataracts. Moderate to severe liver disease: monitor for hypercorticism; consider discontinuing if occurs. Elderly. Pregnancy. Nursing mothers.
Uceris Pharmacokinetics
See Literature
Uceris Interactions
Interactions
May be potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin); consider discontinuing. Avoid grapefruit or grapefruit juice. May be affected by gastric acid reducing agents (eg, PPIs, H2-blockers, antacids).
Uceris Adverse Reactions
Adverse Reactions
Headache, nausea, decreased blood cortisol, upper abdominal pain, fatigue, flatulence, abdominal distension, acne, urinary tract infection, arthralgia, constipation; hypercorticism, adrenal suppression, immunosuppression.
Uceris Clinical Trials
See Literature
Uceris Note
Not Applicable
Uceris Patient Counseling
See Literature
Images
